Скачать с ютуб Targeting Bacterial Metabolites to Manage Irritability in Autism- S. Campbell PhD @Synchrony2021 в хорошем качестве

Targeting Bacterial Metabolites to Manage Irritability in Autism- S. Campbell PhD @Synchrony2021

Stewart Campbell, PhD, is the Senior Vice President of R&D at Axial Therapeutics. He brings 25 years of drug discovery and development experience to Axial. He has built and led R&D teams in early-stage research through to advanced clinical development in small start-ups to mid-sized companies. Prior to joining Axial, Dr. Campbell held various leadership roles at companies including CordenPharma, Surface Logix, Insmed and Boehringer-Ingelheim. Dr. Campbell served as VP of R&D at Ancora Pharmaceuticals, successfully triaging the company through the acquisition by Corden Pharma. While at Surface Logix and Insmed, Dr. Campbell played an integral role in the discovery and development of five clinical drug candidates, including TAK-609 (Phase 3, Takeda) and belumosudil (NDA stage, Kadmon). Prior to post-doctoral research at Duke, Dr. Campbell obtained a PhD in Chemistry from Queen’s University (Canada). He has consulted for several start-up companies in multiple capacities and is co-inventor on more than 15 issued patents. #irritability #behavior #challengingbehaviour 🎥 This talk was part of Synchrony 2021 Online Symposium - 'From Bench to Biopharma', organised by the The BRAIN Foundation in partnership with UC Davis MIND Institute and CalTech. 🎥 For more Synchrony 2021 talks and highlights:    • Synchrony Symposium 2021 - From Bench...   🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 Synchrony https://synchronysymposium.com/ is the first and only international symposium on translational research in #autism, that brings together academia, #biotech, pharmaceutical companies and #venture partners from around the world with the mission to improve health and quality of life of people with #autismspectrumdisorder. 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 🧠 The BRAIN Foundation https://brainfoundation.org/ is a 501c(3) non-profit. The founders of BRAIN envision a world where every child and adult on the autism spectrum is healthy, participates fully in education and employment, and has a better quality of life. It aims to catalyze research that results in evidence-based interventions for the disabilities associated with autism, and also results in better medical standard of care. To accomplish this, it funds impactful research through #philanthropy and our network of partners in the venture, corporate, and grassroots community.